Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

Similar articles for PubMed (Select 20377047)

1.

Select barriers to harm-reduction services for IDUs in eastern Europe.

Curth NK, Hansson LN, Storm F, Lazarus JV.

Cent Eur J Public Health. 2009 Dec;17(4):191-7.

PMID:
20377047
2.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
3.

HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.

Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S.

Int J Drug Policy. 2007 Oct;18(5):426-32. Epub 2007 Feb 15.

PMID:
17854732
4.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA.

Int J Drug Policy. 2010 Sep;21(5):335-42. doi: 10.1016/j.drugpo.2010.02.001. Epub 2010 Feb 26. Review.

PMID:
20189375
5.

Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.

Emmanuelli J, Desenclos JC.

Addiction. 2005 Nov;100(11):1690-700. Erratum in: Addiction. 2006 Apr;101(4):616.

PMID:
16277629
7.
8.

Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.

Emmanuel F, Fatima M.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64. doi: 10.1016/j.drugpo.2007.12.012. Epub 2008 Feb 20.

PMID:
18281206
9.

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D.

Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Review.

PMID:
20219055
10.

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.

Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, Parry J, Lyons M, Goldberg D, Allen E, Hickman M.

Addiction. 2011 Nov;106(11):1978-88. doi: 10.1111/j.1360-0443.2011.03515.x. Epub 2011 Aug 24.

PMID:
21615585
11.

[HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes].

Trujols J, Iraurgi I, Solà I, Ballesteros J, Siñol N, Batlle F, Pérez de Los Cobos J.

Adicciones. 2010;22(2):135-40. Spanish.

PMID:
20549148
12.

Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.

Bobrova N, Sarang A, Stuikyte R, Lezhentsev K.

Int J Drug Policy. 2007 Aug;18(4):313-8. Epub 2007 Mar 21.

PMID:
17689380
13.

Implementation of harm reduction in Central and Eastern Europe and Central Asia.

Sarang A, Stuikyte R, Bykov R.

Int J Drug Policy. 2007 Mar;18(2):129-35. Epub 2006 Dec 19. Review.

PMID:
17689355
14.

Young people and drugs: next generation of harm reduction.

Merkinaite S, Grund JP, Frimpong A.

Int J Drug Policy. 2010 Mar;21(2):112-4. doi: 10.1016/j.drugpo.2009.11.006. Epub 2009 Dec 29.

PMID:
20036526
16.

Global estimates of prevalence of HCV infection among injecting drug users.

Aceijas C, Rhodes T.

Int J Drug Policy. 2007 Oct;18(5):352-8. Epub 2007 Aug 7. Review.

PMID:
17854722
17.

Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R.

J Infect. 2000 Mar;40(2):176-83.

PMID:
10841096
18.

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG.

J Adv Nurs. 2001 Feb;33(3):357-70. Review.

PMID:
11251723
19.

Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.

Goldberg D, Cameron S, McMenamin J.

Commun Dis Public Health. 1998 Jun;1(2):95-7.

PMID:
9644121
20.

Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.

Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, Stephenson R, Graves L.

Int J Drug Policy. 2007 May;18(3):204-12. Epub 2006 Oct 2.

PMID:
17689367
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk